Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 25 matching records.
25 results — page 1 of 2
- Level DNarrative ReviewEurope PMC
Hydrogel-based delivery of MSCs and derivatives for improved diabetic retinopathy therapy
Narrative Review on Systemic / IV, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Res Ther1 citations - Level DNarrative ReviewPubMed
Diabetic Retinopathy and Current Treatment Approaches: From Pathogenesis to Extracellular Vesicle-Based Therapies.
Narrative Review on Face & Skin, Systemic / IV, published in Int J Mol Sci (2026) — summary generated from the PubMed abstract.
- 2026
Int J Mol Sci - Level DNarrative ReviewPubMed
Future Directions in Diabetic Retinopathy Treatment: Stem Cell Therapy, Nanotechnology, and PPARα Modulation.
Narrative Review on Systemic / IV, published in J Clin Med (2025) — summary generated from the PubMed abstract.
- 2025
J Clin Med10 citations - Level DAnimal StudyEurope PMC
Intravenous delivery of mesenchymal stromal cells reverses Müller cell endoplasmic reticulum stress in diabetic retinopathy
Animal Study on Systemic / IV, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther - Level DLaboratory StudyPubMed
Molecular Mechanisms and Therapeutic Implications of Human Pericyte-like Adipose-Derived Mesenchymal Stem Cells in an In Vitro Model of Diabetic Retinopathy.
Laboratory Study on Systemic / IV, published in Int J Mol Sci (2024) — summary generated from the PubMed abstract.
- 2024
Int J Mol Sci7 citations - Level DNarrative ReviewPubMed
Cell and molecular targeted therapies for diabetic retinopathy.
Narrative Review on Type 2 Diabetes, published in Front Endocrinol (Lausanne) (2024) — summary generated from the PubMed abstract.
- 2024
Front Endocrinol (Lausanne) - Level DNarrative ReviewEurope PMC
<i>In Vitro</i> Models of Diabetes: Focus on Diabetic Retinopathy
Narrative Review on Systemic / IV, published in Cells (2024) — summary generated from the PubMed abstract.
- 2024
Cells7 citations - Level DLaboratory StudyPubMed
Protective Effects of Human Pericyte-like Adipose-Derived Mesenchymal Stem Cells on Human Retinal Endothelial Cells in an In Vitro Model of Diabetic Retinopathy: Evidence for Autologous Cell Therapy.
Laboratory Study on Systemic / IV, published in Int J Mol Sci (2023) — summary generated from the PubMed abstract.
- 2023
Int J Mol Sci18 citations - Level DNarrative ReviewPubMed
Stem cells and diabetic retinopathy: From models to treatment.
Narrative Review on Type 2 Diabetes, published in Mol Biol Rep (2023) — summary generated from the PubMed abstract.
- 2023
Mol Biol Rep9 citations - Level DAnimal StudyPubMed
A comparative study between the possible protective role of melatonin versus its combination with adipose derived-mesenchymal stem cells on experimentally induced diabetic retinopathy in adult male albino rats (Histologi
Animal Study on Systemic / IV, published in Ultrastruct Pathol (2023) — summary generated from the PubMed abstract.
- 2023
Ultrastruct Pathol4 citations - Level DNarrative ReviewEurope PMC
Retinal Ischaemia in Diabetic Retinopathy: Understanding and Overcoming a Therapeutic Challenge
Narrative Review on Scar, published in J Clin Med (2023) — summary generated from the PubMed abstract.
- 2023
J Clin Med29 citations - Level DAnimal StudyEurope PMC
Evaluation of Photobiomodulation and Boldine as Alternative Treatment Options in Two Diabetic Retinopathy Models
Animal Study on Systemic / IV, published in Int J Mol Sci (2023) — summary generated from the PubMed abstract.
- 2023
Int J Mol Sci5 citations - Level DAnimal StudyEurope PMC
Preventive Effects of Exosome-Rich Conditioned Medium From Amniotic Membrane-Derived Mesenchymal Stem Cells for Diabetic Retinopathy in Rats
Animal Study on Systemic / IV, published in Transl Vis Sci Technol (2023) — summary generated from the PubMed abstract.
- 2023
Transl Vis Sci Technol10 citations - Level DNarrative ReviewEurope PMC
Contribution of Müller Cells in the Diabetic Retinopathy Development: Focus on Oxidative Stress and Inflammation
Narrative Review on Systemic / IV, published in Antioxidants (Basel) (2022) — summary generated from the PubMed abstract.
- 2022
Antioxidants (Basel)74 citations - Level DNarrative ReviewEurope PMC
Experiment-Based Interventions to Diabetic Retinopathy: Present and Advances
Narrative Review on Systemic / IV, published in Int J Mol Sci (2022) — summary generated from the PubMed abstract.
- 2022
Int J Mol Sci10 citations - Level DAnimal StudyPubMed
Insights into stem cell therapy for diabetic retinopathy: a bibliometric and visual analysis.
Animal Study on Neuroinflammation, Chronic Inflammation, published in Neural Regen Res (2021) — summary generated from the PubMed abstract.
- 2021
Neural Regen Res33 citations - Level DLaboratory StudyPubMed
Pro-angiogenic Activity Discriminates Human Adipose-Derived Stromal Cells From Retinal Pericytes: Considerations for Cell-Based Therapy of Diabetic Retinopathy.
Laboratory Study on Systemic / IV, published in Front Cell Dev Biol (2020) — summary generated from the PubMed abstract.
- 2020
Front Cell Dev Biol13 citations - Level DAnimal StudyPubMed
Adipose mesenchymal stem cells-secreted extracellular vesicles containing microRNA-192 delays diabetic retinopathy by targeting ITGA1.
Animal Study on Chronic Inflammation, published in J Cell Physiol (2020) — summary generated from the PubMed abstract.
- 2020
J Cell Physiol - Level BClinical TrialPubMed
Adult Stem Cell Therapeutics in Diabetic Retinopathy.
Clinical Trial on Face & Skin, Systemic / IV, published in Int J Mol Sci (2019) — summary generated from the PubMed abstract.
- 2019
Int J Mol Sci40 citations - Level DAnimal StudyEurope PMC
Photobiomodulation Inhibits Long-term Structural and Functional Lesions of Diabetic Retinopathy
Animal Study on Systemic / IV, published in Diabetes (2018) — summary generated from the PubMed abstract.
- 2018
Diabetes52 citations - Level DNarrative ReviewPubMed
Mesenchymal stromal/stem cells as potential therapy in diabetic retinopathy.
Narrative Review on Immune Modulation, published in Immunobiology (2018) — summary generated from the PubMed abstract.
- 2018
Immunobiology - Level DAnimal StudyPubMed
Adipose-derived stem cells from diabetic mice show impaired vascular stabilization in a murine model of diabetic retinopathy.
Animal Study on Systemic / IV, published in Stem Cells Transl Med (2015) — summary generated from the PubMed abstract.
- 2015
Stem Cells Transl Med36 citations - Level BClinical TrialPubMed
Stem cell therapies in the treatment of diabetic retinopathy and keratopathy.
Clinical Trial on Neuroinflammation, published in Exp Biol Med (Maywood) (2015) — summary generated from the PubMed abstract.
- 2015
Exp Biol Med (Maywood)25 citations - Level DAnimal StudyPubMed
Regenerative therapeutic potential of adipose stromal cells in early stage diabetic retinopathy.
Animal Study on Neuroinflammation, published in PLoS One (2014) — summary generated from the PubMed abstract.
- 2014
PLoS One89 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406